CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Blood collection +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01516437
NCT01516437N/ACompleted

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD) Aged Between 45-75 Years

GlaxoSmithKline·interventional·Posted Jan 24, 2012·Updated May 17, 2017

In Brief

A clinical study evaluating Blood collection, Swab collection, and 1 other intervention for Respiratory Disorders. Completed, enrolled 73 participants across 3 sites.

Detailed Summary

The present study aims to assess the natural immunity to specific microbial antigens in healthy subjects and in subjects with stable COPD aged between 45-75 years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 24, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJun 28, 2012
Study CompletionDec 20, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 14.4 years ago

Interventions

Blood collectionprocedure

Blood collection at Day 0 (all subjects) and at Month 6 (COPD subjects) for the analysis of serology, cell-mediated immune response.

Swab collectionprocedure

Nasopharyngeal and oropharyngeal swabs collection at Day 0 (All subjects) and at exacerbation visits (COPD subjects).

Sputum collectionprocedure

Sputum collection at Day 0 and at exacerbation visits (COPD subjects)